Syringe News and Research

RSS

New data from efficacy study of CIMZIA in Crohn's disease patients presented

New data from an open-label extension study evaluating the long-term safety and efficacy of CIMZIA® (certolizumab pegol) in moderate to severe Crohn's disease patients demonstrate that 82 percent of patients actively treated with CIMZIA - the only PEGylated anti-TNF-alpha (Tumor Necrosis Factor alpha) - remained in long-term remission without dose escalation up to 3.5 years.

27 Oct 2009

Unilife Medical Solutions accepts US$5.2 million to create 241 new jobs in York County

Unilife Medical Solutions Limited ("Unilife" or "the Company") today announced it has accepted a US$5.2 million offer of assistance from the Commonwealth of Pennsylvania to support the creation of 241 new jobs within York County.

24 Oct 2009

“Protectus Medical Devices - Company Overview” informative video released by E-18

-18 Corp., through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today released an online overview video presented by Dr. John Salstrom, President and CEO of Protectus Medical Devices.

24 Oct 2009

Unilife Medical Solutions relocates manufacturing operations to York County

Governor Edward G. Rendell announced today that nearly 250 new jobs will soon be coming to York County now that state investments have helped to convince a global manufacturing company to expand there.

24 Oct 2009

Unilife Medical Solutions to market its products at pharmaceutical industry event

Unilife Medical Solutions Limited today announced it will be exhibiting at two upcoming pharmaceutical trade shows and conferences.

22 Oct 2009

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Bristol-Myers Squibb Company announced today that new clinical data support continued development of a subcutaneous administration of ORENCIA® (abatacept) for patients with moderate to severe rheumatoid arthritis.

21 Oct 2009

Phase I clinical study of PENNVAX-B preventive DNA vaccine using electroporation technology

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, and the HIV Vaccine Trials Network (HVTN) announced today the initiation of a phase I clinical study of Inovio’s PENNVAX-B preventive DNA vaccine delivered using its proprietary electroporation technology.

19 Oct 2009

Baxter International announces financial results for third quarter 2009; updates full-year financial outlook

Baxter International Inc. today reported solid financial results for the third quarter of 2009, and provided its fourth quarter and updated full-year 2009 financial outlook.

From Baxter International Inc. 15 Oct 2009

Also in Global Health News: 'Delivering as one'; syringe vending machine; hospital preparedness

Rwanda will host a three-day U.N. meeting next week to discuss ways to improve the U.N.'s ability to "provide development assistance in a more coordinated way," the New Times/allAfrica.com reports. "Rwanda is one of the 8 pilot countries implementing the U.N. 'Delivering as One' initiative, as part of the body's reform process," the publication writes. Participants in the meeting will share their experiences and lessons learned from the program since its implementation in 2007 (Gathoni, 10/14).

15 Oct 2009

Clemson bioengineer designing new ways to target drugs

Clemson bioengineer Frank Alexis is designing new ways to target drugs and reduce the chances for side effects.

9 Oct 2009

APP Pharmaceuticals receives FDA approval to market Sumatriptan Succinate Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Sumatriptan Succinate Injection, USP, in two dosage strengths.

8 Oct 2009

New embolization technique offers better clinical outcomes in the treatment of liver cancer

The authors of a newly published paper in the September/October journal Vascular Disease Management conclude that the micro-bland embolization technique possible with Embozene(TM) Color-Advanced Microspheres leads to better clinical outcomes.

6 Oct 2009

Revolutions Medical's new corporate headquarters in Charleston

Revolutions Medical Corporation ("RevMed" or the "Company") (OTCBB: RMCP), producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, today announced that it has moved its expanded operations to new corporate headquarters in Charleston and is hosting a Grand Opening ceremony on October 8th, 2009 at 5:30pm - 7:30pm ET

1 Oct 2009

Excelsior's SwabCap launched at the 23rd Association for Vascular Access conference

Excelsior Medical, one of the leading manufacturers of pre-filled catheter flush syringes and syringe pump systems, announced that it has launched a major new product: the SwabCap™ Luer Access Valve Disinfection Cap.

28 Sep 2009

E-18 Corp. enters dental syringe market, completes US patent filing for the Protectus Safety Dental Syringe

E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company’s market opportunities to include the multi-billion dollar dental syringe market.

24 Sep 2009

Revolution Medical's MRI software suit to be launched at RSNA annual meeting

Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB: RMCP), producers of the Rev Vac safety syringe, today announced that it will debut its evolutionary MRI software suite at the Radiological Society of North America (RSNA) annual meeting at McCormick Place in Chicago on November 29th - December 4th.

23 Sep 2009

Pharmacist Paul Dwork endorses the Protectus Safety Syringe

E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces the release of a letter from Paul Dwork, Pharmacist, and President of Merlin Medical Supply Pharmacy, endorsing the many benefits of the Protectus Safety Syringe.

19 Sep 2009

First Edition: September 17, 2009

Today's headlines focus on two clear story lines: First, the long-awaited and much-anticipated Baucus health overhaul measure was unveiled yesterday; second, it's reception was only lukewarm.

17 Sep 2009

Revolutions Medical unveils the enhanced design of Rev Vac safety syringe

Revolutions Medical Corporation ("Revolutions Medical" or the "Company"), producers of the Rev Vac safety syringe, today detailed further the performance and aesthetic improvements to its flagship Rev Vac syringe, and debuted a highly informative product demonstration video.

15 Sep 2009

IVIS Lumina XR in vivo imaging system from Caliper Life Sciences

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced the IVIS Lumina XR in vivo imaging system, the latest addition to the IVIS product family.

14 Sep 2009

Syringe News and Research

New data from efficacy study of CIMZIA in Crohn's disease patients presented

Unilife Medical Solutions accepts US$5.2 million to create 241 new jobs in York County

“Protectus Medical Devices - Company Overview” informative video released by E-18

Unilife Medical Solutions relocates manufacturing operations to York County

Unilife Medical Solutions to market its products at pharmaceutical industry event

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Phase I clinical study of PENNVAX-B preventive DNA vaccine using electroporation technology

Baxter International announces financial results for third quarter 2009; updates full-year financial outlook

Also in Global Health News: 'Delivering as one'; syringe vending machine; hospital preparedness

Clemson bioengineer designing new ways to target drugs

APP Pharmaceuticals receives FDA approval to market Sumatriptan Succinate Injection

New embolization technique offers better clinical outcomes in the treatment of liver cancer

Revolutions Medical's new corporate headquarters in Charleston

Excelsior's SwabCap launched at the 23rd Association for Vascular Access conference

E-18 Corp. enters dental syringe market, completes US patent filing for the Protectus Safety Dental Syringe

Revolution Medical's MRI software suit to be launched at RSNA annual meeting

Pharmacist Paul Dwork endorses the Protectus Safety Syringe

First Edition: September 17, 2009

Revolutions Medical unveils the enhanced design of Rev Vac safety syringe

IVIS Lumina XR in vivo imaging system from Caliper Life Sciences

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News